Lotze MT - Search Results

1

Report on the ISBTC mini-symposium on biologic effects of targeted therapeutics.

Atkins MB, Carbone D, Coukos G, Dhodapkar M, Ernstoff MS, Finke J, Gajewski TF, Gollob J, Lotze MT, Storkus W, Weiner LM. Atkins MB, et al. Among authors: lotze mt. J Immunother. 2007 Sep;30(6):577-90. doi: 10.1097/CJI.0b013e318064e7b2. J Immunother. 2007. PMID: 17667521 Review.

2

Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes.

Itoh T, Storkus WJ, Gorelik E, Lotze MT. Itoh T, et al. Among authors: lotze mt. J Immunol. 1994 Aug 1;153(3):1202-15. J Immunol. 1994. PMID: 7517974

3

Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer.

Zeh HJ 3rd, Hurd S, Storkus WJ, Lotze MT. Zeh HJ 3rd, et al. Among authors: lotze mt. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):155-61. doi: 10.1097/00002371-199308000-00012. J Immunother Emphasis Tumor Immunol. 1993. PMID: 7904180

4

New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines.

Maeurer MJ, Storkus WJ, Kirkwood JM, Lotze MT. Maeurer MJ, et al. Among authors: lotze mt. Melanoma Res. 1996 Feb;6(1):11-24. doi: 10.1097/00008390-199602000-00003. Melanoma Res. 1996. PMID: 8640065 Review.

5

IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts.

Tahara H, Lotze MT, Robbins PD, Storkus WJ, Zitvogel L. Tahara H, et al. Among authors: lotze mt. Hum Gene Ther. 1995 Dec;6(12):1607-24. doi: 10.1089/hum.1995.6.12-1607. Hum Gene Ther. 1995. PMID: 8664385 No abstract available.

6

Murine models of cancer cytokine gene therapy using interleukin-12.

Tahara H, Zitvogel L, Storkus WJ, Robbins PD, Lotze MT. Tahara H, et al. Among authors: lotze mt. Ann N Y Acad Sci. 1996 Oct 31;795:275-83. doi: 10.1111/j.1749-6632.1996.tb52677.x. Ann N Y Acad Sci. 1996. PMID: 8958939

7

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines.

Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Garcia-Prats MD, DeLeo AB, Lotze MT. Mayordomo JI, et al. Among authors: lotze mt. Stem Cells. 1997;15(2):94-103. doi: 10.1002/stem.150094. Stem Cells. 1997. PMID: 9090785 Review.

8

Gene-based strategies for the immunotherapy of cancer.

Tüting T, Storkus WJ, Lotze MT. Tüting T, et al. Among authors: lotze mt. J Mol Med (Berl). 1997 Jul;75(7):478-91. doi: 10.1007/s001090050133. J Mol Med (Berl). 1997. PMID: 9253711 Review.

9

Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro.

Tjandrawan T, Martin DM, Maeurer MJ, Castelli C, Lotze MT, Storkus WJ. Tjandrawan T, et al. Among authors: lotze mt. J Immunother. 1998 Mar;21(2):149-57. doi: 10.1097/00002371-199803000-00009. J Immunother. 1998. PMID: 9551367

10

Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.

Robertson MJ, Cameron C, Atkins MB, Gordon MS, Lotze MT, Sherman ML, Ritz J. Robertson MJ, et al. Among authors: lotze mt. Clin Cancer Res. 1999 Jan;5(1):9-16. Clin Cancer Res. 1999. PMID: 9918197 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

573 results

Search Page

Filters